Fund Holdings — Commodore Capital LP

Total Portfolio Value:
$1.36B
Total Bought:
$231.92M
Total Sold:
$400.89M
Net Transaction:
-$168.97M
Notable People:
Michael Jonathan Kramarz, Robert Egen Turrell Atkinson, Commodore Capital Gp Llc
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Merus N V3,350,0003,874,182+524,182$167.37M$162.91M11.94%-$4.46M
Vaxcyte, Inc.(PCVX)920,0001,625,000+705,000$105.13M$133.02M9.75%+$27.89M
Nuvalent Inc940,0001,621,600+681,600$96.16M$126.94M9.30%+$30.78M
Xenon Pharmaceuticals Inc.(XENE)2,700,0002,740,000+40,000$106.30M$107.41M7.87%+$1.11M
Enliven Therapeutics Inc4,100,0004,205,000+105,000$104.71M$94.61M6.93%-$10.10M
Vera Therapeutics, Inc.CL A(VERA)2,475,0001,958,600-516,400$109.39M$82.83M6.07%-$26.57M
Soleno Therapeutics Inc1,260,0001,525,000+265,000$63.62M$68.55M5.02%+$4.93M
Alkermes plcSHS(ALKS)2,900,0002,300,000-600,000$81.17M$66.15M4.85%-$15.02M
Nurix Therapeutics, Inc.(NRIX)1,650,0003,000,000+1,350,000$37.08M$56.52M4.14%+$19.44M
Cogent Biosciences, Inc.(COGT)7,539,9306,881,629-658,301$81.43M$53.68M3.93%-$27.75M
Spyre Therapeutics, Inc.(SYRE)1,988,0841,988,0840$58.47M$46.28M3.39%-$12.19M
Viridian Therapeutics, Inc.(VRDN)2,550,1242,400,000-150,124$58.02M$46.01M3.37%-$12.01M
Scholar Rock Holding Corporation(SRRK)0950,000+950,000$0$41.06M3.01%+$41.06M
Centessa Pharmaceuticals PlcADS1,350,0002,218,425+868,425$21.59M$37.16M2.72%+$15.57M
Pharvaris N V
COM
1,911,4331,911,4330$35.40M$36.64M2.69%+$1.24M
Mind Medicine Mindmed Inc8,000,0004,308,425-3,691,575$45.52M$29.99M2.20%-$15.53M
Oruka Therapeutics, Inc.(ORKA)1,369,7141,419,714+50,000$33.57M$27.53M2.02%-$6.04M
Cardiff Oncology, Inc.(CRDF)05,384,616+5,384,616$0$23.37M1.71%+$23.37M
Inhibikase Therapeutics, Inc.(IKT)05,925,000+5,925,000$0$19.26M1.41%+$19.26M
Neurogene Inc.(NGNE)200,000800,000+600,000$8.39M$18.29M1.34%+$9.90M
Bright Minds Biosciences Inc.(DRUG)0500,000+500,000$0$18.01M1.32%+$18.01M
ORIC Pharmaceuticals, Inc.(ORIC)2,000,0002,000,0000$20.50M$16.14M1.18%-$4.36M
Apogee Therapeutics Inc290,000290,0000$17.03M$13.14M0.96%-$3.90M
ABIVAX Société AnonymeADS(ABVX)1,284,1101,284,1100$14.79M$9.40M0.69%-$5.39M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
750,000750,0000$7.51M$7.63M0.56%+$127.5K
Helix Acquisition Corp IiCL A500,000500,0000$5.22M$5.25M0.38%+$25.1K
Celcuity Inc.(CELC)1,522,332400,000-1,122,332$22.70M$5.24M0.38%-$17.46M
Vistagen Therapeutics, Inc.(VTGN)1,575,0001,575,0000$4.74M$4.65M0.34%-$94.5K
Avalo Therapeutics, Inc.(AVTX)483,000483,0000$4.59M$3.59M0.26%-$999.8K
Third Harmonic Bio Inc1,360,569237,704-1,122,865$18.44M$2.45M0.18%-$15.99M
Nkarta, Inc.(NKTX)4,662,073351,848-4,310,225$21.07M$876.1K0.06%-$20.20M
Arvinas, Inc.(ARVN)1,200,0000-1,200,000$29.56M$0—-$29.56M
C4 Therapeutics, Inc.(CCCC)3,410,3840-3,410,384$19.44M$0—-$19.44M
Cabaletta Bio, Inc.(CABA)1,100,0000-1,100,000$5.19M$0—-$5.19M
Celldex Therapeutics, Inc.(CLDX)1,618,9370-1,618,937$55.03M$0—-$55.03M
Instil Bio, Inc.(TIL)150,9290-150,929$10.16M$0—-$10.16M
Kura Oncology, Inc.(KURA)1,800,0000-1,800,000$35.17M$0—-$35.17M
Perspective Therapeutics, Inc.(CATX)3,350,0000-3,350,000$44.72M$0—-$44.72M
Rhythm Pharmaceuticals, Inc.(RYTM)650,0000-650,000$34.05M$0—-$34.05M
Syndax Pharmaceuticals, Inc.(SNDX)885,0000-885,000$17.04M$0—-$17.04M
Page 1 of 1
Commodore Capital LP — 13F Holdings — Q4 2024 | TickerTrail